======= POU6F2 ======= == Gene Information == * **Official Symbol**: POU6F2 * **Official Name**: POU class 6 homeobox 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11281|11281]] * **UniProt**: [[https://www.uniprot.org/uniprot/P78424|P78424]] * **Interactions**: [[https://thebiogrid.org/search.php?search=POU6F2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20POU6F2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609062|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the POU protein family characterized by the presence of a bipartite DNA binding domain, consisting of a POU-specific domain and a homeodomain, separated by a variable polylinker. The DNA binding domain may bind to DNA as monomers or as homo- and/or heterodimers, in a sequence-specific manner. The POU family members are transcriptional regulators, many of which are known to control cell type-specific differentiation pathways. This gene is a tumor suppressor involved in Wilms tumor (WT) predisposition. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.[provided by RefSeq, Oct 2009]. * **UniProt Summary**: Probable transcription factor likely to be involved in early steps in the differentiation of amacrine and ganglion cells. Recognizes and binds to the DNA sequence 5'-ATGCAAAT-3'. Isoform 1 does not bind DNA. |Pou| |Homeobox| |ganglion mother cell fate determination| |stem cell fate determination| |stem cell fate commitment| |cell fate determination| |stem cell differentiation| |visual perception| |sensory perception of light stimulus| |cell fate commitment| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |DNA-binding transcription factor activity| |sensory perception| |central nervous system development| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |nervous system process| |DNA binding| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |system process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-1.77| |[[:results:exp121|Golgicide-A 2μM R03 exp121]]|1.73| |[[:results:exp111|R-DABN 8μM R03 exp111]]|2.01| |[[:results:exp33|Rotenone 2μM R00 exp33]]|2.06| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|2.32| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|2.33| |[[:results:exp93|DABN racemic mixture R03 exp93]]|2.83| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|3.25| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5783 * **Expression level (log2 read counts)**: 0.25 {{:chemogenomics:nalm6 dist.png?nolink |}}